400-920-2911 sales@csnpharm.cn
CAS No.: 1642297-01-5
Synonyms: SRN-927
GDC-0927, also known as SRN-927, is a next-generation oral SERD, appears to have greater potential than GDC-0810 to be a best-in-class SERD molecule.
规格 | 价格 | 促销价格 | 库存 | 数量 |
---|
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02316509 | Breast Cancer | Phase 1 | Active, not recruiting | November 30, 2019 | United States, Massachusetts ... more >> Massachusetts General Hospital. Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Stony Brook University Medical Center Stony Brook, New York, United States, 11794 United States, Tennessee Sarah Cannon Cancer Center Germantown, Tennessee, United States, 38138 Vanderbilt Ingram Cancer Ctr Nashville, Tennessee, United States, 37232 Spain ICO I Hospitalet Hospital Duran i Reynals Instituto Catalan de Oncologia de Hospitalet ICO L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Onkologikoa - Kutxaren Institutu Onkologikoa San Sebastian, Guipuzcoa, Spain, 20014 Hospital Univ Vall d'Hebron; Servicio de Oncologia Barcelona, Spain, 08035 MD Anderson Cancer Center Madrid - España; Servicio de Farmacia Madrid, Spain, 28033 Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital General Universitario Gregorio Maranon Madrid, Spain, 28040 HM Sanchinarro - CIOCC Madrid, Spain, 28050 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Collapse << |
实验方案
技术信息
CAS号 | 1642297-01-5 | 储存条件 |
|
|||
分子式 | C28H28FNO4 | 运输 | 蓝冰 | |||
分子量 | 461.52 | 别名 | SRN-927 | |||
溶解度 |
|
动物实验配方 |